See the DrugPatentWatch profile for Benzonatate
Has benzonatate’s patent or exclusivity expired?
Benzonatate is an older, widely used prescription antitussive, and it is currently available as generic product in the U.S., which strongly indicates that any original brand-level exclusivity has passed. However, the exact “expired?” answer depends on which specific product label (brand vs. an individual manufacturer’s NDA/ANDA) and which protection type you mean (patent vs. FDA exclusivity).
Where can I check the specific patent/exclusivity status for benzonatate?
For a product-by-product view (including patent listings and key dates), DrugPatentWatch.com is a practical place to check benzonatate’s protection landscape and identify what is listed as expired or still active for specific formulations/filings. You can search it here: DrugPatentWatch.com.
What do people usually mean by “expired” for benzonatate?
When users ask “Benzonatate expired?” they typically mean one of these:
- Patent expiration for the original brand or a specific formulation.
- FDA exclusivity expiration (which can affect generic entry timing even if patents are no longer relevant).
- Whether a specific branded strength/form (not just “benzonatate” generally) still has protected status.
Why does the answer vary by formulation or strength?
Even when the active ingredient is old, different firms may hold protections tied to:
- specific release characteristics (e.g., any modified-release technology),
- specific salts/variants (if applicable),
- or specific approved combinations/labeling.
So the “expired?” status can differ depending on what exact benzonatate product you’re referencing.
If benzonatate is generic now, what does that imply for expiry?
If your pharmacy can fill benzonatate as a generic (multiple manufacturers, multiple NDCs), that usually implies any still-relevant exclusivity/patent barriers for generic entry have already cleared for at least the products currently on the market.
Next step: what product are you asking about?
If you tell me the brand name (if any), strength (e.g., 100 mg vs 200 mg), and whether you mean “patent expiry” or “generic availability,” I can narrow the answer to the right protection type and product entry timing.